Glimepiride as insulin sensitizer: increased liver and muscle responses to insulin.

Glimepiride as insulin sensitizer: increased liver and muscle responses to insulin.

Item
http://www.wikidata.org/entity/Q46691035
Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statementBiochemical alterations during the obese-aging process in female and male monosodium glutamate (MSG)-treated mice.Effects of Sulfonylureas on Peroxisome Proliferator-Activated Receptor γ Activity and on Glucose Uptake by Thiazolidinediones.Metformin, but not glimepiride, improves carotid artery diameter and blood flow in patients with type 2 diabetes mellitus.GLUT4 content decreases along with insulin resistance and high levels of inflammatory markers in rats with metabolic syndrome.MicroRNAs-Mediated Regulation of Skeletal Muscle GLUT4 Expression and Translocation in Insulin Resistance.Muscle IGF-1-induced skeletal muscle hypertrophy evokes higher insulin sensitivity and carbohydrate use as preferential energy substrate.Omega-3 Fatty Acids Supplementation Differentially Modulates the SDF-1/CXCR-4 Cell Homing Axis in Hypertensive and Normotensive Rats.Soybean and sunflower oil-induced insulin resistance correlates with impaired GLUT4 protein expression and translocation specifically in white adipose tissue.Glitazone-like action of glimepiride and glibenclamide in primary human adipocytes.Resveratrol Improves Glycemic Control in Type 2 Diabetic Obese Mice by Regulating Glucose Transporter Expression in Skeletal Muscle and Liver.Hepatosteatosis and hepatic insulin resistance are blunted by argirein, an anti-inflammatory agent, through normalizing endoplasmic reticulum stress and apoptosis in diabetic liver.Carbohydrate- and lipid-enriched meals acutely disrupt glycemic homeostasis by inducing transient insulin resistance in rats.Advanced glycation end products-induced insulin resistance involves repression of skeletal muscle GLUT4 expression.
P2860

Glimepiride as insulin sensitizer: increased liver and muscle responses to insulin.

Item
http://www.wikidata.org/entity/Q46691035
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Glimepiride as insulin sensitizer: increased liver and muscle responses to insulin.
@en
Glimepiride as insulin sensitizer: increased liver and muscle responses to insulin.
@nl
type
label
Glimepiride as insulin sensitizer: increased liver and muscle responses to insulin.
@en
Glimepiride as insulin sensitizer: increased liver and muscle responses to insulin.
@nl
prefLabel
Glimepiride as insulin sensitizer: increased liver and muscle responses to insulin.
@en
Glimepiride as insulin sensitizer: increased liver and muscle responses to insulin.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Glimepiride as insulin sensitizer: increased liver and muscle responses to insulin
@en
P2093
P2860
P304
P31
P356
10.1111/J.1463-1326.2008.00870.X
P433
P478
P50
P577
P698
P921